Yale New Haven Health.
Dartmouth-Hitchcock Medical Center.
Clin J Oncol Nurs. 2020 Feb 1;24(1):11-14. doi: 10.1188/20.CJON.11-14.
With morbidity and mortality related to opioid use continuing to increase, clinicians need to better understand the risk for opioid misuse in patient populations. Screening for opioid misuse risk has not been routinely adopted as a standard practice in clinical settings. A pilot study was performed to determine the feasibility of screening for future opioid misuse risk using the Opioid Risk Tool (ORT) in an ambulatory oncology clinic. Twelve patients in this sample scored in the moderate- to high-risk range for aberrant behavior, and 8 patients reported a personal history of substance abuse, indicating a need for opioid misuse risk screening in populations of patients with cancer. Because it is easy and quick to use, the ORT may be a feasible tool to incorporate into standard practice.
由于与阿片类药物使用相关的发病率和死亡率持续上升，临床医生需要更好地了解患者人群中阿片类药物滥用的风险。在临床环境中，尚未常规采用筛查阿片类药物滥用风险作为标准做法。进行了一项试点研究，以确定在肿瘤门诊中使用阿片类药物风险工具（ORT）筛查未来阿片类药物滥用风险的可行性。该样本中的 12 名患者在行为异常方面的评分处于中至高风险范围，8 名患者报告有药物滥用个人史，这表明癌症患者人群需要进行阿片类药物滥用风险筛查。由于 ORT 使用简便快捷，因此它可能是一种可行的纳入标准实践的工具。
